Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way.
Deborah R. Leitner,Gema Frühbeck,Volkan Yumuk,Karin Schindler,Dragan Micic,Euan Woodward,Hermann Toplak +6 more
Reads0
Chats0
TLDR
Therapeutic strategies are warranted, which can be easily used for the management of obese patients with type 2 diabetes to achieve their glycemic and weight loss goals.Abstract:
Obesity is a chronic metabolic disease affecting adults and children worldwide. It has become one of the leading causes of death, as obesity is known to be the main risk factor for a number of non-communicable diseases, in particular type 2 diabetes. This close relationship led to the connotation 'diabesity', highlighting the fact that the majority of individuals with diabetes are overweight or obese. Until today the BMI is still used to classify overweight and obesity. Since reduced muscle mass is highly prevalent throughout the BMI range, the measurement of body composition is strongly recommended. Moreover, it is essential for monitoring the course of weight reduction, which is part of every effective anti-obesity treatment. Weight reduction can be achieved via different weight loss strategies, including lifestyle intervention (diet and exercise), pharmacotherapy, or bariatric surgery. However, not all of these strategies are suitable for all patients, and any further needs should be considered. Besides, attention should also be drawn to concomitant therapies. These therapies may promote additional weight gain and further trigger the deterioration of blood glucose control. Thus, therapeutic strategies are warranted, which can be easily used for the management of obese patients with type 2 diabetes to achieve their glycemic and weight loss goals.read more
Citations
More filters
Journal ArticleDOI
Gut microbiome and type 2 diabetes: where we are and where to go?
Sapna Sharma,Prabhanshu Tripathi +1 more
TL;DR: The published literature was reviewed for better understanding of the dynamics of gut microbiota, factors that potentially induce gut microbiome dysbiosis and their relation to the progression of T2D, and special emphasis was given to understand the gut microbiome induced breaching of intestinal barriers and/or tight junctions and their connection to insulin resistance.
Journal ArticleDOI
Diet and exercise in the prevention and treatment of type 2 diabetes mellitus.
TL;DR: This Review highlights the evidence from clinical trials that diet-induced weight loss interventions can be used to treat type 2 diabetes mellitus and preliminary work suggests that pretreatment glycaemic status could be use to stratify patients in order to optimize dietary recommendations.
Journal ArticleDOI
Marine Collagen as A Promising Biomaterial for Biomedical Applications
TL;DR: This review focuses on the expanding role of marine collagen (MC)-based scaffolds for biomedical applications, and holds great promise as a biomaterial for developing medical products and therapeutics.
Journal ArticleDOI
Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model.
Torben Rasmussen,Caroline M. Junker Mentzel,Witold Kot,Josué L. Castro-Mejía,Simone Zuffa,Jonathan R. Swann,Lars Hestbjerg Hansen,Finn K. Vogensen,Axel Kornerup Hansen,Dennis Sandris Nielsen +9 more
TL;DR: Transfer of caecal viral communities from mice with a lean phenotype into mice with an obese phenotype led to reduced weight gain and normalised blood glucose parameters relative to lean mice, hypothesized to be mediated via FVT-induced GM changes.
Journal ArticleDOI
Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders
TL;DR: The aim of the present review is to summarise the current knowledge about the beneficial effects reported for edible seaweed polyphenols in the amelioration of these prevalent conditions, focusing on both preclinical and clinical studies.
References
More filters
Journal ArticleDOI
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
William C. Knowler,Elizabeth Barrett-Connor,Sarah E. Fowler,Richard F. Hamman,John M. Lachin,Elizabeth A. Walker,David M. Nathan +6 more
TL;DR: In this paper, the authors compared a lifestyle intervention with metformin to prevent or delay the development of Type 2 diabetes in nondiabetic individuals. And they found that the lifestyle intervention was significantly more effective than the medication.
Journal ArticleDOI
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies.
TL;DR: The proportion of Asian people with a high risk of type 2 diabetes and cardiovascular disease is substantial at BMIs lower than the existing WHO cut-off point for overweight (> or =25 kg/m2), but available data do not necessarily indicate a clear BMI cut-offs point for all Asians for overweight or obesity.
Journal ArticleDOI
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies
Gary Whitlock,Sarah Lewington,Paul Sherliker,Robert Clarke,Jonathan Emberson,Jim Halsey,Nawab Qizilbash,Rory Collins,Richard Peto +8 more
TL;DR: Below the range 22.5-25 kg/m(2), BMI was associated inversely with overall mortality, mainly because of strong inverse associations with respiratory disease and lung cancer, despite cigarette consumption per smoker varying little with BMI.
Journal ArticleDOI
National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
Mariel M. Finucane,Gretchen A Stevens,Melanie J. Cowan,Goodarz Danaei,John K Lin,Christopher J. Paciorek,Gitanjali M Singh,Hialy R. Gutierrez,Yuan Lu,Adil N. Bahalim,Farshad Farzadfar,Leanne M Riley,Majid Ezzati +12 more
TL;DR: In this paper, the authors estimated trends and their uncertainties of mean BMI for adults 20 years and older in 199 countries and territories, and used a Bayesian hierarchical model to estimate mean BMI by age, country, and year.
Journal ArticleDOI
Global burden of obesity in 2005 and projections to 2030
TL;DR: Overweight and obesity are important clinical and public health burdens worldwide and national programs for the prevention and treatment of overweight, obesity and related comorbidities and mortalities should be a public health priority.